Strain-Counterstrain Treatment of Piriformis Pain
Launched by LOMA LINDA UNIVERSITY · Aug 20, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment called Strain-Counterstrain for people who experience pain from a muscle in the buttocks area known as the piriformis muscle. This pain can be related to conditions like low back pain, piriformis syndrome, and other issues in the lower back. The goal of the study is to find a safe and effective way to help relieve this type of pain without using invasive methods, such as surgery.
To be eligible for the trial, participants need to be between 18 and 65 years old and have a specific tender point in the piriformis muscle that a doctor can identify during an examination. However, some people may not qualify if they have certain limitations in hip movement, cannot lie on their stomach, are unable to attend two sessions in the same month, or have other medical conditions like active cancer or pregnancy. If selected, participants will attend treatment sessions aimed at reducing their pain. Importantly, those involved will not be allowed to receive other treatments like massage or acupuncture during the study period.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 to 65 years of age
- • Tender point (or trigger point) in piriformis muscle determined by physical exam
- Exclusion criteria:
- • Less than 45 degrees of active hip flexion, less than 5 degrees of active hip internal rotation or less than 30 degrees of active hip external rotation, on side of affected piriformis
- • Unable to lay prone
- • Non-English speaker
- • Inability to attend 2 sessions within the same month
- • Active cancer
- • Pregnant
- • Diagnosis of lumbar radiculopathy
- • Greater than grade 1 lumbar spondylolisthesis
- • Presence of lumbar region Pars Defect
- • Receiving massage, acupuncture, chiropractic treatments, osteopathic treatments during study period.
About Loma Linda University
Loma Linda University is a prominent academic institution dedicated to advancing health and wellness through innovative research and education. As a sponsor of clinical trials, Loma Linda University leverages its extensive medical and scientific expertise to conduct rigorous studies aimed at improving patient outcomes and public health. With a commitment to ethical practices and patient safety, the university collaborates with a diverse network of healthcare professionals and researchers to explore novel therapeutic interventions and enhance clinical knowledge across various medical disciplines. Through its clinical trials, Loma Linda University seeks to contribute valuable insights to the medical community and foster advancements in healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Loma Linda, California, United States
Patients applied
Trial Officials
Mickey Lui
Principal Investigator
Loma Linda University Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials